Ascendis Pharma A (ASND) Times Interest Earned (2014 - 2026)
Ascendis Pharma A (ASND) posted Times Interest Earned of $0.37 for Q1 2026, up 131.06% sequentially from $0.16 in Q4 2025, and down 84.15% YoY from $2.33 in Q1 2025.
Ascendis Pharma A (ASND) Times Interest Earned (2014 - 2026) Analysis & Trends
Ascendis Pharma A has reported Times Interest Earned for 13 years, with the latest figure at $0.37 in Q1 2026.
- Quarterly Times Interest Earned fell 84.15% year-over-year to $0.37 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$0.02 (down 100.0% YoY) and the FY2025 annual result came in at -$0.66, up 76.34% from the prior year.
- Times Interest Earned grew to $0.37 in Q1 2026 per ASND's latest filing, from $0.16 in the prior quarter.
- Over five years, Times Interest Earned peaked at $478.53 in Q4 2022 and troughed at -$29.5 million in Q4 2024.
- A 5-year average of -$1.7 million and a median of -$3.82 in 2024 frame the typical range for Times Interest Earned.
- The sharpest annual moves came in 2024 and 2025: Times Interest Earned slumped 677993512.51% in 2024, then soared 465.34% in 2025.
- Over 5 years, Times Interest Earned stood at $478.53 in 2022, then slumped by 100.91% to -$4.35 in 2023, then plunged by 677993512.51% to -$29.5 million in 2024, then surged by 100.0% to $0.16 in 2025, then jumped by 131.06% to $0.37 in 2026.
- According to Business Quant data, Times Interest Earned over the past three periods registered $0.37, $0.16, and $0.16 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.84 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 24.64 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -0.19 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.18 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -0.01 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.61 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2.82 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.08 |
| 10 | Ascendis Pharma A | 15.40 Bn | 14.73 Bn | 268.20 Mn | -0.37 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.37 |
| Dec 31, 2025 | 0.16 |
| Sep 30, 2025 | 0.16 |
| Jun 30, 2025 | -1.60 |
| Mar 31, 2025 | 2.33 |
| Dec 31, 2024 | -29.46 Mn |
| Sep 30, 2024 | -3.82 |
| Jun 30, 2024 | -6.79 |
| Mar 31, 2024 | -0.64 |
| Dec 31, 2023 | -4.35 |
| Sep 30, 2023 | -5.48 |
| Jun 30, 2023 | -15.09 |
| Mar 31, 2023 | -14.60 |
| Dec 31, 2022 | 478.53 |
| Sep 30, 2022 | -3.50 |
| Jun 30, 2022 | -15.04 |
| Mar 31, 2022 | -23.71 |
| Dec 31, 2021 | 287.93 |
| Sep 30, 2021 | -110.53 |
| Jun 30, 2021 | -9.69 |